8-K filing — Evofem Biosciences, Inc. (EVFM)
Filed: 2026-07-20 AccNo: 0001493152-26-033910 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-07-20 AccNo: 0001493152-26-033910 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarTop Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. AVGO receives Outperform rating with $455 PT.
Read original at benzingaBaird analyst Luke Junk initiates coverage on Hubbell (NYSE:HUBB) with a Outperform rating and announces Price Target of $550.
Read original at benzingaCNBC's Jim Cramer offers his takes on various companies, including CME Group, Alcoa, Rocket Lab, Fortinet, HCA Healthcare and Hubbell.
Read original at benzinga2023 was a year where investor expectations collided with business reality. While markets recovered from the 2022 selloff, several companies continued to lose billions in market value as growth stories weakened,
Read original at benzinga